EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments

Shalindu Malshan Jayawickrama iD, Piyumi Madhushani Ranaweera iD, Ratupaskatiye Gedara Gunaratnege Roshan Pradeep iD, Yovanthi Anurangi Jayasinghe iD, Kalpani Senevirathna iD, Abdul Jabbar Hilmi, Rajapakse Mudiyanselage Gamini Rajapakse iD, Kehinde Kazeem Kanmodi iD, Ruwan Duminda Jayasinghe iD

Cancer Reports · 2024

DOI: 10.1002/cnr2.2045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Reports, 2024. Verfasst von Shalindu Malshan Jayawickrama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research in Oral Cancer, Faculty of Dental Sciences, University of Peradeniya, Kandy, Sri Lanka. Hauptthemen laut MEDLINE: Precision Medicine, Head and Neck Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Precision healthcare has entered a new era because of the developments in personalized medicine, especially in the diagnosis and treatment of head and neck squamous cell carcinoma (HNSCC). This paper explores the dynamic landscape of personalized medicine as applied to HNSCC, encompassing both current developments and future prospects. Recent Findings The integration of personalized medicine strategies into HNSCC diagnosis is driven by the utilization of genetic data and biomarkers. Epigenetic biomarkers, which reflect modifications to DNA that can influence gene expression, have emerged as valuable indicators for early detection and risk assessment. Treatment approaches within the personalized medicine framework are equally promising. Immunotherapy, gene silencing, and editing techniques, including RNA interference and CRISPR/Cas9, offer innovative means to modulate gene expression and correct genetic aberrations driving HNSCC. The integration of stem cell research with personalized medicine presents opportunities for tailored regenerative approaches. The synergy between personalized medicine and technological advancements is exemplified by artificial intelligence (AI) and machine learning (ML) applications. These tools empower clinicians to analyze vast datasets, predict patient responses, and optimize treatment strategies with unprecedented accuracy.

Conclusion

The developments and prospects of personalized medicine in HNSCC diagnosis and treatment offer a transformative approach to managing this complex malignancy. By harnessing genetic insights, biomarkers, immunotherapy, gene editing, stem cell therapies, and advanced technologies like AI and ML, personalized medicine holds the key to enhancing patient outcomes and ushering in a new era of precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckArtificial IntelligenceBiomarkers

Stichwörter der Autor:innen

artificial intelligencebiomarkergenetic datahead and neck squamous cell carcinomamachine learningpersonalized medicinetargeted therapy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Centre for Research in Oral Cancer, Faculty of Dental Sciences, University of Peradeniya, Kandy, Sri Lanka.
  • Faculty of Information Technology, Horizon Campus, Colombo, Sri Lanka.
  • Oncology and Radiotherapy Unit, National Hospital, Kandy, Sri Lanka.
  • Department of Chemistry, Faculty of Sciences, University of Peradeniya, Kandy, Sri Lanka.
  • School of Dentistry, University of Rwanda, Kigali, Rwanda.
  • Faculty of Dentistry, University of Puthisastra, Phnom Penh, Cambodia.

ORCID-Profile: Shalindu Malshan Jayawickrama, Piyumi Madhushani Ranaweera, Ratupaskatiye Gedara Gunaratnege Roshan Pradeep, Yovanthi Anurangi Jayasinghe, Kalpani Senevirathna, Rajapakse Mudiyanselage Gamini Rajapakse, Kehinde Kazeem Kanmodi, Ruwan Duminda Jayasinghe

Zitieren

APA

Jayawickrama, S. M., Ranaweera, P. M., Pradeep, R. G. G. R., Jayasinghe, Y. A., Senevirathna, K., Hilmi, A. J., Rajapakse, R. M. G., Kanmodi, K. K., & Jayasinghe, R. D. (2024). Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments. Cancer Reports. https://doi.org/10.1002/cnr2.2045

Vancouver

Jayawickrama SM, Ranaweera PM, Pradeep RGGR, Jayasinghe YA, Senevirathna K, Hilmi AJ, et al. Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments. Cancer Reports. 2024. doi:10.1002/cnr2.2045

BibTeX
@article{Jayawickrama2024,
  author = {Jayawickrama, Shalindu Malshan and Ranaweera, Piyumi Madhushani and Pradeep, Ratupaskatiye Gedara Gunaratnege Roshan and Jayasinghe, Yovanthi Anurangi and Senevirathna, Kalpani and Hilmi, Abdul Jabbar and Rajapakse, Rajapakse Mudiyanselage Gamini and Kanmodi, Kehinde Kazeem and Jayasinghe, Ruwan Duminda},
  title = {Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.2045}
}
Kostenlos starten →